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ABSTRACT: Screening target microorganisms from a
mutated recombinant library plays a crucial role in advancing
synthetic biology and metabolic engineering. However,
conventional screening tools have several limitations regarding
throughput, cost, and labor. Here, we used the ﬂuid array
platform to conduct high-throughput screening (HTS) that
identiﬁed Escherichia coli ‘TesA thioesterase mutants produc-
ing elevated yields of free fatty acids (FFAs) from a large (106)
mutant library. A growth-based screening method using a
TetA-RFP fusion sensing mechanism and a reporter-based
screening method using high-level FFA producing mutants
were employed to identify these mutants via HTS. The platform was able to cover >95% of the mutation library, and it screened
target cells from many arrays of the ﬂuid array platform so that a post-analysis could be conducted by gas chromatography. The
‘TesA mutation of each isolated mutant showing improved FFA production in E. coli was characterized, and its enhanced FFA
production capability was conﬁrmed.
■ INTRODUCTION
Free fatty acids (FFAs) have attracted a lot of attention
because of their potential as a controllable and renewable
energy source.1,2 FFAs are also useful in the production of
biofuels, cosmetics, lubricants/solvents, and pharmaceutical
drugs. The corn-based production of FFAs is problematic
because it competes with food production, increases reﬁnery
costs, decreases land-use eﬃciency, and raises environmental
concerns. However, microbial-based FFA production shows
potential in terms of its economic cost, quick production time,
and smaller space requirements.3−6 Because Escherichia coli is a
commonly used industrial organism, various approaches have
been suggested that may improve the microbial production of
FFAs.
Over the last decade, the overexpression of the rate-limiting
enzyme and deregulation of the degradation pathway have
been implemented to increase the microbial-based production
capacity of FFAs and their precursors, leading to 21.5 g/L of
FFA with 0.5 g/L/h productivity.7−12 Microbial FFAs are
mainly synthesized from acyl-ACP (acyl carrier protein) by the
enzyme thioesterase I (TesA).5 The enzymatic characteristics
of TesA have been thoroughly characterized; therefore, several
previous studies have used it to increase the cellular production
of FFAs.13−16 However, Jiang and Cronan17 reported that the
overexpression of the enzymatic component in the fatty acid
synthesis (FAS) pathway does not guarantee maximum FFA
production in E. coli. Therefore, it is required to ensure optimal
activity from key enzymes and components in the FAS
pathway and subsequently improve production yields.
To ﬁnd an alternate FFA production method that relieves
the dependence on the excess expression level of ‘TesA, which
requires signal sequence-deﬁcient E. coli acyl-CoA thioesterase
I, we previously found a ‘TesA mutant using a conventional
high-throughput screening (HTS) approach. We screened a
‘TesA mutant library to identify mutants that produce more
FFAs than the wild-type (WT) enzyme.16 The isolation of
desired mutants from a large mutant library is typically labor-
intensive. Therefore, a two-step selection system was applied:
(1) FFA-dependent tetracycline resistance for the growth-
based enrichment of the desired mutants and then (2) selective
isolation through FFA-dependent RFP expression with FACS-
Calibur. However, only a few samples from the mutant library
could be isolated during the growth-based enrichment phase
because of competitive growth in the antibiotic’s presence.
Still, the growth of mutants that possibly display suboptimal
FFA production can be aﬀected by competitive crosstalk in the
over-populated condition.18 Therefore, this screening method
requires compartmentalization to avoid such crosstalk.
Several microﬂuidic approaches have been implemented to
overcome diﬃculties with compartmentalization and achieve
complete coverage of large mutant libraries. These methods
have several beneﬁts when applied to HTS as an alternative to
conventional experimental methods.19−22 Screening a library of
more than 103 microbial mutants has never been achieved
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using a microﬂuidic platform due to the trade-oﬀ between the
compartmentalized environment of HTS and the diﬃculties
associated with the selective isolation of desired mutants. We
previously described a ﬂuid array platform that had been
speciﬁcally designed for the HTS of a large, microbial random
mutation library.22 The simplicity of device fabrication and the
ease of identifying extraordinary samples mean that the ﬂuid
array platform was successful in several diﬀerent HTS
applications that involved the growth-based and reporter-
based screening of a microbial mutant library.23,24
This current study combines the previously mentioned ﬂuid
array screening approach and two-step screening (cell
enrichment in tetracycline-containing medium and RFP
expression dependent on cellular FFA production). This
resulted in the isolation of ‘TesA mutants that display higher
FFA production than WT ‘TesA. We applied a hybrid
screening procedure that used both reporter-based and
growth-based screening simultaneously. In addition, we
employed the ﬂuid array platform against the random mutant
library in an isolated microenvironmental culture condition to
avoid the exclusion of suboptimal mutants. The selected ‘TesA
mutants were tested to conﬁrm that cells expressing mutants
produced higher amounts of FFAs than cells expressing WT
‘TesA.
■ EXPERIMENTAL METHODS
Materials and Reagents. The ﬂuid array platform was
fabricated with two types of oil with diﬀerent speciﬁc gravities
(SG) to compartmentalize the aqueous solutions: hydrocarbon
oil (hexadecane, SG = 0.76, Sigma-Aldrich, Korea) and
ﬂuorinated oil (FC-40, SG = 1.61, Sigma-Aldrich, Korea).
Cells were cultured in Luria Bertani broth (LB, Sigma-Aldrich,
Korea) supplemented with antibiotics such as ampicillin (Amp,
75 μg/mL), chloramphenicol (Cm, 50 μg/mL), and
tetracycline (Tet, 50 μg/mL) (all purchased from Bioshop
Canada Inc.). An LB agar plate (1% w/v Agar, Becton
Dickinson) was prepared for colony formation.
HTS with the ﬂuid array used M9 minimal medium
(Minimal salt 5×, Becton Dickinson, Franklin Lakes, NJ,
USA) supplemented with 2 mM MgSO4, 0.1 mM CaCl2, 0.5%
(w/v) glucose, an appropriate antibiotic concentration, and 0.3
mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) for the
growth-based screening of the mutant library. Yeast extract 1
g/L (w/v) and trace elements were also added. The trace
elements consisted of 2.4 g of FeCl3·6H2O, 0.3 g of CoCl2·
6H2O, 0.15 g of CuCl2·2H2O, 0.3 g of ZnCl2, 0.3 g of
Na2MO4·2H2O, 0.075 g of H3BO3, and 0.495 g of MnCl2·
4H2O per liter. The pH was maintained at 7.0 with 100 mM of
sodium phosphate buﬀer (pH 7.0).
According to the previous report22 and product sheet of the
ﬂuorinated oil, the limit of solubility of ﬂuorinated oil toward
distilled water is 0.02% (v/v) at theoretical maximum.
Therefore, to prevent the aqueous phase of the ﬂuid array
shrinking, FC-40 oil was mixed with distilled water (0.1% v/v)
using a rotary shaker at 60 °C prior to the screening
experiment. After the overnight stirring, the distilled water
was not thoroughly mixed with the oils; thus, the ﬁnal
concentration of water in the oil was estimated to be
approximately 0.02% (v/v). The distilled water saturated
with ﬂuorinated oil was used to prepare LB broth and M9
minimal medium for microbial experiments in this study.
Preparation of the Bacterial Cells and GC Analysis of
the FFAs. E. coli MG1655 was the parental strain for all strains
used in this research. The cell concentration was determined
by measuring the optical density at a wavelength of 600 nm
(OD600) using a spectrophotometer (Libra S22, Biochrom Ltd,
Cambridge, UK). For HTS, the ‘TesA mutant library and fatty
acid biosensor (FAB) cells harboring the biosensor plasmid
pFAB were prepared as described previously.16
GC analysis was conducted to analyze microbial FFA
production in a precise, quantitative manner. The selected cells
were cultivated in LB medium and diluted 1:100 in the
previously described M9 minimal medium supplemented with
2% (w/v) glucose. When the OD600 reached around 1.0, IPTG
was added to reach a ﬁnal concentration of 0.3 mM for the
induction of ‘TesA expression. After 48 h of incubation that
resulted in microbial FFA production, 500 μL of each culture
was stored at −20 °C until analysis. Next, 50 μL of 6 N HCl,
500 μL of ethyl acetate, and 50 μL of 1 g/L methyl
nonadecanoate (Sigma-Aldrich) were added in sequence as an
internal standard. FFAs were extracted from the cultures by
vortexing for 30 s and centrifuging for 2 min. An additional
500 μL of ethyl acetate was added, and the same extraction
procedure was repeated. Extracted FFAs were methylated by
adding 100 μL of MeOH: 6 N HCl (9:1, v/v) and 100 μL of
TMS-diazomethane (Sigma-Aldrich).
The FFA analysis was performed with a GC system (Agilent
7890A) equipped with a ﬂame ionization detector and DB-5
column (30 m × 0.25 mm, Agilent Technologies). The FFA
concentrations were measured by comparing each peak with
the external standards composed of C10−22 fatty acid methyl
esters (Sigma-Aldrich). An oven temperature of 60 °C was
maintained for 2.5 min, increased to 250 °C at 20 °C/min, and
maintained for 4 min. Finally, the temperature was increased to
325 °C at a rate of 10 °C/min, which was maintained for 5
min.
Statistical Modeling of the Library Coverage and
Optimal Seeding Condition. Two diﬀerent genetic screen-
ing tools that are similar to a dual-selection system were
simultaneously employed in this ﬂuid array screening process
to obtain mutants of ‘TesA with increased functionality. In our
previous research,16 the ﬁrst screening tool was considered
growth-based. It used the modiﬁed genetic circuit for the FFA-
dependent tetracycline resistance gene (tetA) expression,
which diﬀerentiates the cellular doubling time to enable the
enrichment of cells that overproduce FFA. The second
screening tool was reporter-based and employed an FFA-
sensing reporter system. It showed a dose−response of
ﬂuorescence intensity caused by the presence of intracellular
fatty acids. Optimal experimental conditions of FFA-dependent
growth and RFP expression were previously investigated.
To adequately cover the mutant library, we constructed a
statistical formula (presented below) derived from the Poisson
distribution.25 According to eq 1, P is deﬁned as the probability
of covering the whole mutation library, f is the number of
mutants in the library represented by collected colonies, and N
is deﬁned as the amount of coverage required to get P.
= −
−( )
N
Pln(1 )
ln 1
f
1
(1)
For the 106-random mutation library of ‘TesA, an experi-
ment with an initial seeding number of 30 cells per chamber
and 20 ﬂuid array devices was carefully designed after
considering the library coverage. Therefore, according to the
above equation (eq 1), the experiment screened approximately
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1.8 × 106 samples, which statistically covered >95% of the
mutation library. Thirty cells were initially seeded and
incubated for 20 h to ensure the diﬀerentiation and enrichment
of cells whose growth was FFA-dependent. In addition, the
incubation time enhanced the ﬂuorescence signal from the
FAB biosensor plasmid.
In terms of throughput, the 20 ﬂuid array chips prepared and
used in parallel covered >95% of the ‘TesA mutant library. It
was assumed that 30 unique, initially seeded library cells
resulted in the growth of only a few mutants because the
enrichment from FFA-dependent tetracycline resistance was
used as the ﬁrst selective pressure. As a second screening
method, we measured the ﬂuorescence intensity in the ﬂuid
array device chambers generated by RFP, which corresponded
to the intracellular FFA concentration in a quantitative
manner. Samples with the highest ﬂuorescence intensities
(top 1%) were selected. The cells in the samples were isolated
and named as UFM. The fatty acid production from at least
ﬁve individual colonies per chamber was analyzed by GC.
Fabrication of the Fluid Array Device. The microwell in
the ﬂuid array device was 100 μm in diameter and 150 μm
deep having 3000 arrays in a single device (3 × 3 cm). The
spacing between individual arrays on a device was redesigned
from 4 × 2 to 3 × 2 matrices based on the recovery eﬃciency
of the glass capillary extraction process in our previous work.22
The SU-8 (Microchem 2075, Newton, MA, USA) master mold
was fabricated using standard photolithography processes. The
processed surface of a Si-wafer was silanized using trichloro-
(3,3,3-triﬂuoropropyl) silane (Sigma-Aldrich, Korea) in a
vacuum jar for 1 h. Polydimethylsiloxane (PDMS, Sylgard
184 Silicone Elastomer Kit, Dow Corning, Midland, MI, USA)
was then cast, cured, and peeled oﬀ to prepare the ﬂuid array
devices. To ensure that the environment was fully moisturized,
the demolded PDMS devices were dipped in distilled water for
several hours, resulting in a fully hydrated state (i.e., the
highest solubility of water into PDMS). This ensured that the
aqueous ﬂuid in the microwell remained stable without
apparent volume shrinkage over 24 h. During long-term
incubation (>12 h), the ﬂuid array device was half-dipped in oil
and half-dipped in water to minimize array chamber drying.
Experimental Setup and Data Analysis. An inverted
ﬂuorescence microscope (IX-71, Olympus, Tokyo, Japan)
equipped with a CCD camera (Clara, Andor, Belfast, Northern
Ireland) and 1.5×, 10×, and 20× objective lenses was used to
acquire all ﬂuorescence images from the ﬂuid array device. The
images were automatically acquired using a microscope stage
controller (MAC5000/Bioprecision2, Ludl Electronic Prod-
ucts, Hawthorne, NY, USA) with a multidimensional
acquisition function from the Metamorph 7.1 (Molecular
Devices, Sunnyvale, CA, USA) image software. The
ﬂuorescence intensities of the images were then performed
with high-throughput analysis using a custom-made m-ﬁle in
MATLAB R2014a (Mathworks, Natick, MA, USA). Image J
(NIH, Bethesda, MD, USA) and OriginPro 8 (OriginLab,
Northampton, MA, USA) were used for additional data
analysis and necessary image processing. A manually controlled
probe positioner (PB50, MS Tech, Hwaseong, Korea) was
used to ﬁx capillary tubes to extract target cells. Target cells
were extracted with fused-silica capillary tubes (CAT no.
#1068150011, Polymicro Technologies, Phoenix, AZ, USA)
with 25.3 μm inner diameter and 360 μm outer diameter (OD)
and commercially available insulin syringes with OD = 200 μm.
Experimental Protocol for Screening. The screening
procedure was introduced in our previous work22 and is shown
in Figure 1. The demolded PDMS ﬂuid array devices were
treated with oxygen plasma under 15 sccm of O2 and 70 W for
30 s (Cute-MP, Femto Science, Hwaseong, Korea). The
mutation library in the medium (M9 minimal, SG: 1.0) with
0.3 mM of IPTG was deposited on the plasma-treated device
to ﬁll all microwell chambers. After removing the residual
medium on the device by the PDMS slab, the device was then
placed onto a Petri dish ﬁlled with ﬂuorinated oil (FC-40, SG:
1.61). The mutant library with approximately 30 cells in each
chamber was incubated for 24 h, and the ﬂuid array device was
integrated with the high-throughput image analysis based on
the ﬂuorescent intensity from pFAB of the mutant library. The
device was then ﬂipped over to another Petri dish ﬁlled with
Figure 1. HTS strategy used to identify mutants with increased ‘TesA functionality. (a) Wild type ‘tesA. (b) Introduction of mutation by error-
prone PCR. (c) Construction of random mutant library. (d) Generation of ﬂuid array devices for screening of 106 library. (e) HTS based on FFA
biosensors. (f) Post GC analysis for FFA production of selected mutants. (g) Genotypic identiﬁcation for mutated region of selected ‘tesA. (h) In
vitro recombination of identiﬁed ‘TesA in an expression vector plasmid, pBbB6c (i) electro-transformation of the expression vector to wild type of
E. coli MG1655. (j) Reproduction results of FFA from recombinant ‘tesA of the expression vector.
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hydrocarbon oil (hexadecane, SG: 0.76) to retain the aqueous
volume of the ﬂuid array from the dehydration, so that top 1%
of selective extractions of extraordinary mutants can be
performed using glass capillary tubes for post-analysis of
mutant cells. Because the recovery of the isolated cells was
already optimized in the previous work,22 the isolated mutants
were cultured in fresh medium. Finally, we identiﬁed the
mutated region of ‘tesA of the isolated mutants for further
investigation of the eﬀects of mutations on FFA production.
■ RESULTS AND DISCUSSION
Isolation of Mutants Producing High Levels of FFA.
Several sensing systems were previously utilized to detect and
quantify the production level of various biochemicals.26,27 To
screen mutants overproducing FFAs in the ‘TesA mutant
library, we used a previously constructed FFA biosensor
composed of a TetA-RFP fusion protein under FadR-regulated
promoter. In E. coli, the FadR acts as an acyl-CoA-responsive
transcriptional regulator that binds DNA to inhibit the
expression of several genes involved in fatty acid degradation
pathway.28 As FFAs can be converted into acyl-CoAs, the
intracellular concentration of acyl-CoAs is well correlated with
FFAs in E. coli.26 In the FAB, high level of acyl-CoAs releases
of the protein from its DNA-binding sites and increases the
expression of TetA-RFP under a FadR-repressed promoter,
resulting in high tetracycline resistance and red ﬂuorescence.16
This FFA biosensor was employed to selectively isolate highly
functional ‘TesA mutants.16,29 For the screening approach, the
ﬂuid array platform exploited growth-based screening using
FFA-dependent tetracycline resistance during enrichment and
reporter-based screening using FFA-dependent RFP expres-
sion. This study used this combined screening approach to
integrate two genetic screening tools into a one-step screening
approach. As previously discussed, we determined that using
30 individual mutant cells per chamber was appropriate for the
FFA-dependent cell growth in medium containing tetracycline
to cover the 106 mutant library. After incubation in the ﬂuid
array platforms and data analysis, the capillary extraction of
cells in the chamber was conducted. Each cell broth was
extracted in descending order of ﬂuorescence signals produced
from each chamber depending on RFP expression (Figure 1).
Finally, 18 samples (UFM 1−18) were chosen based on the
hybrid screening strategy, and their FFA production was
analyzed by GC (Figure 2). The isolated cells were incubated
repeatedly and compared to the ﬂuorescence signal of the
negative control (MG1655) in visualized images (Figure 3).
Mutants showing a higher ﬂuorescent signal also showed
Figure 2. (Left) All 18 of the isolated mutants were identiﬁed as UFM, then the FFA production yield was analyzed by normalization against FFA
production of E. coli MG1655 expressing WT ‘TesA. Each UFM strain had mutations in the ‘TesA gene. (Right) The average FFA production
yields were measured by GC analysis for (i) the mutants selectively extracted by order of ﬂuorescence intensity and (ii) the randomly extracted 20
mutants.
Figure 3. (a) Fluorescence microscopy of four recultivated ‘TesA mutants and the WT ‘TesA control. (b) Quantiﬁed ﬂuorescence intensities of the
four ‘TesA mutants.
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increased FFA production according to the results of GC
analysis.
To examine possible correlations between the screening
performance of the ﬂuid array and FFA production levels, the
selected mutants were categorized into two separate groups.
The ﬁrst group consisted of 18 mutants collected from the top
<1% of the chambers that showed the highest ﬂuorescence
intensities from the ﬂuid array device, and another group of 20
randomly selected samples was used as a comparison group.
The average titer of FFAs from the ﬁrst group was signiﬁcantly
higher than that of the second group (Figure 2). The results of
the ﬁrst group with the higher titer of FFA validated the
screening approach used in this study.
Genetic Identiﬁcation of the Isolated Mutants. DNA
sequencing was conducted to characterize the ‘TesA mutations
in each mutant as shown in Figure 1 and Table 1. The GC
analysis data in Figure 2 were plotted against the relative FFA
production levels compared to WT ‘TesA. ‘TesA mutations
showed signiﬁcant changes in the amino acid sequence of
‘TesA. We found that some mutations overlapped with our
previous ﬁndings and we discovered new ‘TesA mutants that
almost doubled FFA production. The substitution of aspartic
acid for glycine at the 74th amino acid in ‘TesA increased FFA
production (Figure 2). This result was consistent with a
previous study showing that a substitution mutation at D74 to
G produced 1.5-fold more FFA.16 D74 resides in an N-
terminus loop (residues 75−80) that moves when ‘TesA
interacts with its substrates. Therefore, Asp 74 might regulate
the loop’s movement during catalysis.30 Therefore, we
hypothesized that substituting at the 74th amino acid
inﬂuences the interaction between substrates and ‘TesA,
resulting in higher FFA production. No research has been
reported on the 171st amino acid of ‘TesA; however, it might
be involved in increased FFA production as previously
hypothesized.16 A change in 122nd residue of ‘TesA might
inﬂuence the movement of F121, which surrounds the
substrate-binding crevice, changing the substrate aﬃnity as a
result.30,31 Mutants harboring L7Q, L4I, and I6V exhibited an
approximately 1.4-fold increase in FFA production. Although
the roles of these residues have not been characterized,
mutations in the N-terminal of ‘TesA typically aﬀect its
activity.32 It is diﬃcult to explain how two mutations (i.e.,
V144A and L51R) can improve FFA production because they
have been neither identiﬁed nor examined in previous studies.
Mutations in noncatalytic residues have been known to alter
substrate speciﬁcity and ligand binding, driven by structural
changes in the protein.33 Therefore, V144A and L51R
mutations may act similarly.
Over the last decade, altering substrate speciﬁcity, enhancing
its activity, and deregulating its allosteric regulation have led to
increases in the production of desired products.34−36 Cells
containing mutations at L7, L51, D74, and V144 have
accounted for 33.3, 16.6, and 11.1% of the 13 mutants isolated
from the ‘TesA library, respectively. This result indicates that
the combined screening approach selectively supports the
growth of FFA-overproducing cells in the ﬂuid array chamber
and can identify ‘TesA mutants with enhanced functionality.
Eﬀect of ‘TesA Mutations on FFA Production.
Throughout the ﬂuid array platform screening, several genetic
mutants of ‘TesA were characterized by DNA sequencing the
isolated cells. To conﬁrm that the increase in FFA production
was caused by mutations in ‘TesA (but not by mutations in
genes on the same chromosome such as FAS or acetyl-CoA
carboxylase), we veriﬁed FFA production when mutations
were introduced into WT MG1655. After transformation with
a plasmid that harbors speciﬁc mutations (I6V, L7Q L51R, or
D74G), GC analysis of those mutations showed 1.3−1.7-fold
increased FFA production above that of WT ‘TesA (Figure 4).
These results indicate that the isolated ‘TesA mutants directly
increase FFA production compared to the WT ‘TesA without
any concerns regarding other mutations on the chromosomal
DNA. With the exception of our earlier work,16 no studies have
reported the overproduction of FFA caused by amino acid
alterations in ‘TesA. Therefore, the ‘TesA mutants with
increased functionality identiﬁed in the current study provide
proof that combining the ﬂuid array device and biotechno-
logical approaches can accelerate the production of FFA-
derived chemicals and biofuels.
■ CONCLUSIONS
Conventional HTS approaches for microbial screening suﬀer
from diﬃculties in compartmentalization and throughput. Our
previous research has attempted to overcome such limitations
by applying two diﬀerent screening pressures that were
genetically designed. In this study, we utilized a hybrid
screening approach composed of two screening strategies:
Table 1. Mutation Characterization for the Screened ‘TesA
Mutants and the Number of Overlapped Mutation Residues
over the Total Screened Mutants
mutations on
‘TesA
number of
overlapped
mutations
(percentage)
fold increase
in FFA
production remarks
L7Q 6/18 (33.3) 1.3
L51R 3/18 (16.6) 1.3
D74G 2/18 (11.1) 1.7 same mutation
(D74) from Shin
et al.16
V144A 2/18 (11.1) 1.4
L4I 1/18 (5.5) 1.2
I6V 1/18 (5.5) 1.3
S47P, E143K 1/18 (5.5) 1.3
P24P, L51P,
L104L
1/18 (5.5) 1.2
S10N, T84P,
S122N,
A171T
1/18 (5.5) 1.2 same mutation
(A171) from Shin
et al.16
Figure 4. FFA production of cells harboring each of the four
mutations. The expression of mutated ‘TesA was induced with 0.3
mM IPTG. The black bar indicates FFA production of E. coli
MG1655 harboring WT ‘TesA.
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growth-based screening and reporter gene-based screening. A
random library of 106 mutants was prepared and screened,
resulting in the identiﬁcation of several ‘TesA mutants that
overproduce fatty acids, showing an almost two-fold increase
compared to the WT ‘TesA. Four mutants (‘TesA with I6V,
L7Q, L51R, and D74G) accounted for approximately 70% of
isolated mutants, indicating that the screening system used in
this study successfully isolated FFA-overproducing cells from
the large mutant library. Finally, we believe that the HTS
application used in this study and the isolated ‘TesA mutants
may introduce a new direction for the microbial production of
fatty acids throughout the random engineering of the target
gene.
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